Examples of using Cellcept in English and their translations into Hungarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
CellCept 500 mg powder for concentrate for solution for infusion is indicated in combination with ciclosporin
CellCept 500 mg powder for concentrate for solution for infusion solution should not be mixed
CellCept 500 mg powder for concentrate for solution for infusion is used together with other medicines known as ciclosporin and corticosteroids.
Before starting CellCept treatment, women of child bearing potential should have a pregnancy test
Cellcept is provided in a 20 mL type I clear glass vial with a grey butyl rubber stopper
Decrease in MPA Cmax and AUC(0-12h) by 30% and 25%, respectively, were observed when CellCept was concomitantly administered with sevelamer without any clinical consequences(i.e. graft rejection).
Patients receiving CellCept should be monitored for neutropenia, which may be related to CellCept itself, concomitant medications,
Patients receiving CellCept should be instructed to report immediately any evidence of infection,
In particular, tell your doctor or pharmacist if you are taking any of the following medicines before you start CellCept.
In particular, tell your doctor or nurse if you are taking any of the following medicines before you start CellCept.
CellCept has been helpful in reversing active lupus kidney disease(lupus renal disease) and in maintaining remission after it is established.
The full name of your medicine is CellCept 500 mg powder for concentrate for solution for infusion.
The full name of your medicine is CellCept 500 mg powder for concentrate for solution for infusion.
CellCept is not recommended for use in children after heart
The most serious risk associated with CellCept is the possible development of cancer, particularly lymphoma and skin cancer.
The European Commission granted a marketing authorisation valid throughout the European Union for CellCept to Roche Registration Limited on 14 February 1996.
The initial dose of CellCept 500 mg powder for concentrate for solution for infusion should be given within 24 hours following transplantation.
peripheral venous infusion were phlebitis and thrombosis, both observed at 4% in patients treated with CellCept 500 mg powder for concentrate for solution for infusion.
Two vials of CellCept 500 mg powder for concentrate for solution for infusion are used for preparing each 1 g dose.
bone marrow depression in patients treated with CellCept, some of which have been fatal.